Patients with AML Who Achieve Long Term Complete Remission Do Not Have a Normal Life Expectancy When Compared to the General Population. Analysis of 3,012 Patients Enrolled on 9 Consecutive ECOG-ACRIN Trials

Introduction Several studies reported that AML patients who remain in long-term remission after allogeneic transplant (allo-HCT) or autologous transplant (auto-HCT) have a shorter life expectancy, compared to the general population. However, little is known about the life expectancy of adult long-te...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2021-11, Vol.138 (Supplement 1), p.690-690
Hauptverfasser: Ganzel, Chezi, Roopcharan, Kevin, Sun, Zhuoxin, Rowe, Jacob M., Fernandez, Hugo F, Paietta, Elisabeth M., Luger, Selina M., Lazarus, Hillard M, Cripe, Larry D, Douer, Dan, Wiernik, Peter H., Tallman, Martin S., Litzow, Mark R.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!